Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
Abroad (travel likely)RecruitingPHASE1
Conditions
type1diabetes · Obesity
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Yale Pediatric Diabetes Research, New Haven, Connecticut, United States
Study leads
Michelle Van Name, MD
Principal Investigator
Yale University